Gene symbol | Chromo- some |
Coordinates (bp, mm10) | Size (bp) | Strand | Feature Type | Gene name |
---|---|---|---|---|---|---|
Gm46858 | 4 | 2676 | - | protein coding gene | predicted gene, 46858 | |
Cpgi14301 | 4 | 1772 | CpG island | CpG island 14301 | ||
Tssr37296 | 4 | 114 | + | TSS region | transcription start site region 37296 | |
Slc44a1 | 4 | 182065 | + | protein coding gene | solute carrier family 44, member 1 | |
Tssr37297 | 4 | 32 | + | TSS region | transcription start site region 37297 | |
Tssr37298 | 4 | 2 | + | TSS region | transcription start site region 37298 | |
Cpgi14302 | 4 | 187 | CpG island | CpG island 14302 | ||
Mopkd1 | 4 | 128 | QTL | modifier of polycystic kidney disease progression 1 | ||
Abbp2 | 4 | 40324229 | QTL | A/J and C57BL/6 blood pressure 2 | ||
nmf111 | 4 | 26052934 | heritable phenotypic marker | neuroscience mutagenesis facility, 111 | ||
D4Mit111 | 4 | 128 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 111 | ||
Nmf191 | 4 | 32899409 | heritable phenotypic marker | neuroscience mutagenesis facility, 191 | ||
1700060J05Rik | 4 | 1714 | - | antisense lncRNA gene | RIKEN cDNA 1700060J05 gene | |
Tssr41771 | 4 | 25 | - | TSS region | transcription start site region 41771 | |
Tssr37299 | 4 | 6 | + | TSS region | transcription start site region 37299 | |
Tssr37300 | 4 | 6 | + | TSS region | transcription start site region 37300 | |
9130223C08Rik | 4 | 594 | unclassified gene | RIKEN cDNA 9130223C08 gene | ||
Gm33729 | 4 | 46676 | - | lncRNA gene | predicted gene, 33729 | |
Cpgi14303 | 4 | 1168 | CpG island | CpG island 14303 | ||
Tssr37301 | 4 | 61 | + | TSS region | transcription start site region 37301 | |
Tssr37302 | 4 | 45 | + | TSS region | transcription start site region 37302 | |
Fsd1l | 4 | 75538 | + | protein coding gene | fibronectin type III and SPRY domain containing 1-like | |
Tssr37303 | 4 | 14 | + | TSS region | transcription start site region 37303 | |
Tssr41772 | 4 | 11 | - | TSS region | transcription start site region 41772 | |
Gm12470 | 4 | 1036 | + | pseudogene | predicted gene 12470 | |
Tssr37304 | 4 | 9 | + | TSS region | transcription start site region 37304 | |
Fktn | 4 | 53056 | + | protein coding gene | fukutin | |
Cpgi14304 | 4 | 831 | CpG island | CpG island 14304 | ||
Tssr37305 | 4 | 57 | + | TSS region | transcription start site region 37305 | |
Gm25445 | 4 | 298 | - | unclassified non-coding RNA gene | predicted gene, 25445 | |
Cpgi14305 | 4 | 483 | CpG island | CpG island 14305 | ||
Tssr37306 | 4 | 12 | + | TSS region | transcription start site region 37306 | |
Tal2 | 4 | 7180 | + | protein coding gene | T cell acute lymphocytic leukemia 2 | |
Rps15a-ps8 | 4 | 386 | - | pseudogene | ribosomal protein S15A, pseudogene 8 | |
D4Mit184 | 4 | 102 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 184 | ||
Tssr41773 | 4 | 10 | - | TSS region | transcription start site region 41773 | |
Cpgi14306 | 4 | 540 | CpG island | CpG island 14306 | ||
Tssr37307 | 4 | 93 | + | TSS region | transcription start site region 37307 | |
Tmem38b | 4 | 35974 | + | protein coding gene | transmembrane protein 38B | |
Tssr37308 | 4 | 24 | + | TSS region | transcription start site region 37308 | |
D4Mit240 | 4 | 125 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 240 | ||
Tssr37309 | 4 | 12 | + | TSS region | transcription start site region 37309 | |
Tssr37310 | 4 | 1 | + | TSS region | transcription start site region 37310 | |
Cpgi14307 | 4 | 161 | CpG island | CpG island 14307 | ||
n-R5s185 | 4 | 118 | + | rRNA gene | nuclear encoded rRNA 5S 185 | |
Gm12468 | 4 | 403 | + | pseudogene | predicted gene 12468 | |
Cpgi14308 | 4 | 406 | CpG island | CpG island 14308 | ||
Gm23745 | 4 | 124 | + | snoRNA gene | predicted gene, 23745 | |
Gm33840 | 4 | 3041 | - | lncRNA gene | predicted gene, 33840 | |
D4Mit320 | 4 | 112 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 320 | ||
Skts-fp1 | 4 | -70610548 | QTL | skin tumor susceptibility in FVB and PWK 1 |